Antimicrobial Prophylaxis in Urological Surgery
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Surgical site infection (SSI) is defined as an infection occurring within one month from surgery or intervention. SSIs are classified into three categories: Clean, clean-contaminated, and contaminated. They are defined as procedures that avoid entering the urinary tract, involve entry of the urinary tract, and involve the bowels, respectively. The purpose of antimicrobial prophylaxis (AMP) is to protect the surgical wound from contamination by normal bacterial flora. AMP should be based on penicillin with beta-lactamase inhibitors, or first- or second-generation cephalosporins. Broad-spectrum antimicrobials, such as third- and fourth- generation cephalosporins or carbapenems, should be used to treat postoperative infections but not AMP. AMP should be started no less than 30 minutes prior to the start of the operation. AMP should be administered by a single dose or be terminated within 24 hours in cases of transurethral, clean, or clean-contaminated surgery, and within 2 days in cases of bowl (contaminated) surgery. These guidelines are applicable preoperatively only for non-infected, low-risk patients. The risk of patients for infection should be evaluated preoperatively, such as with a urine culture test. In cases with preoperative infection or bacteriuria that can cause an SSI or urinary tract infection following surgery, patients must receive adequate preoperative treatment based on their individual situation.
Abstract
Surgical site infection (SSI) is defined as an infection occurring within one month from surgery or intervention. SSIs are classified into three categories: Clean, clean-contaminated, and contaminated. They are defined as procedures that avoid entering the urinary tract, involve entry of the urinary tract, and involve the bowels, respectively. The purpose of antimicrobial prophylaxis (AMP) is to protect the surgical wound from contamination by normal bacterial flora. AMP should be based on penicillin with beta-lactamase inhibitors, or first- or second-generation cephalosporins. Broad-spectrum antimicrobials, such as third- and fourth- generation cephalosporins or carbapenems, should be used to treat postoperative infections but not AMP. AMP should be started no less than 30 minutes prior to the start of the operation. AMP should be administered by a single dose or be terminated within 24 hours in cases of transurethral, clean, or clean-contaminated surgery, and within 2 days in cases of bowl (contaminated) surgery. These guidelines are applicable preoperatively only for non-infected, low-risk patients. The risk of patients for infection should be evaluated preoperatively, such as with a urine culture test. In cases with preoperative infection or bacteriuria that can cause an SSI or urinary tract infection following surgery, patients must receive adequate preoperative treatment based on their individual situation.
참고문헌 (50)
- Mangram AJ, "Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee", Infect Control Hosp Epidemiol, 20, pp.250~278 (1999)
- Matsumoto T, "Japanese guidelines for prevention of perioperative infections in urological field", Int J Urol, 14, pp.890~909 (2007)
- Yamamoto S, "Essential Japanese guidelines for the prevention of perioperative infections in the urological field : 2015 edition", Int J Urol, 23, pp.814~824 (2016)
- Grabe M, "Guidelines on urological infections", pp.76~85 (2013), European Association of Urology
- Wolf JS Jr, "Best practice policy statement on urologic surgery antimicrobial prophylaxis", J Urol, 179, pp.1379~1390 (2008)
- Koch CG, "Is it time to refine? An exploration and simulation of optimal antibiotic timing in general surgery", J Am Coll Surg, 217, pp.628~635 (2013)
- Togo Y, "Antimicrobial prophylaxis to prevent perioperative infection in urological surgery : a multicenter study", J Infect Chemother, 19, pp.1093~1101 (2013)
- McDonald M, "Single-versus multiple-dose antimicrobial prophylaxis for major surgery : a systematic review", Aust N Z J Surg, 68, pp.388~396 (1998)
- Ho VP, "Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery", Surg Infect (Larchmt), 12, pp.255~260 (2011)
- George AK, "Surgical site infection rates following laparoscopic urological procedures", J Urol, 185, pp.1289~1293 (2011)
- Tanaka K, "Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin(1 : 4ratio)for prevention of postoperative infections after radical cystectomy", J Infect Chemother, 18, pp.175~179 (2012)
- Shigemura K, "Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion", J Infect Chemother, 18, pp.479~484 (2012)
- Taoka R, "Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy : multicenter cohort study", J Infect Chemother, 19, pp.926~930 (2013)
- Dicker AP, "Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy?", Tech Urol, 6, pp.104~108 (2000)
- Alsaywid BS, "Antibiotic prophylaxis for transurethral urological surgeries : systematic review", Urol Ann, 5, pp.61~74 (2013)
- Yokoyama M, "Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor : a feasibility study", Int J Urol, 16, pp.61~63 (2009)
- Berry A, "Prophylactic antibiotic use in transurethral prostatic resection : a meta-analysis", J Urol, 167, pp.571~577 (2002)
- Qiang W, "Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000bacteria per ml: a systematic review", J Urol, 173, pp.1175~1181 (2005)
- Wagenlehner FM, ""Urological Infections" of German Society of Urology. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim", sulfamethoxazole versus a control group in patients undergoing TUR of the prostate, 2005, pp.47, 549~556
- Sohn DW, "Risk factors of infectious complication after ureteroscopic procedures of the upper urinary tract", J Infect Chemother, 19, pp.1102~1108 (2013)
- Matsumoto M, "Prevention of infectious complication and its risk factors after urological procedures of the upper urinary tract", Urol Int, 88, pp.43~47 (2012)
- Paick SH, "Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent", Urology, 62, pp.214~217 (2003)
- Ozgur BC, "Bacterial colonization of double J stents and bacteriuria frequency", Kaohsiung J Med Sci, 29, pp.658~661 (2013)
- Lu Y, "Antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary : a systematic review and meta-analysis", J Urol, 188, pp.441~448 (2012)
- Shen P, "Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi : a systematic review and meta-analysis", J Urol, 186, pp.1328~1335 (2011)
- Fujita K, "Complicating risk factors for pyelonephritis after extracorporeal shock wave lithotripsy", Int J Urol, 7, pp.224~230 (2000)
- Shigeta M, "A clinical study on upper urinary tract calculi treated with extracorporeal shock wave lithotripsy (ESWL) monotherapy, with regard to bacteriuria before ESWL treatment", Nihon Hinyokika Gakkai Zasshi, 84, pp.866~872 (1993)
- Dinçel C, "Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types", J Endourol, 12, pp.1~3 (1998)
- Charton M, "Urinary tract infection in percutaneous surgery for renal calculi", J Urol, 135, pp.15~17 (1986)
- Doğan HS, "Antibiotic prophylaxis in percutaneous nephrolithotomy : prospective study in 81 patients", J Endourol, 16, pp.649~653 (2002)
- Mariappan P, "One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis : a prospective controlled study", BJU Int, 98, pp.1075~1079 (2006)
- Bag S, "One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis : a prospective controlled study", Urology, 77, pp.45~49 (2011)
- Knopf HJ, "Perioperative antibiotic prophylaxis in ureteroscopic stone removal", Eur Urol, 44, pp.115~118 (2003)
- Togo Y, "Occurrence of infection following prostate biopsy procedures in Japan : Japanese Research Group for Urinary Tract Infection(JRGU)-a multi-center retrospective study", J Infect Chemother, 20, pp.232~237 (2014)
- Carignan A, "Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?", Eur Urol, 62, pp.453~459 (2012)
- Hasegawa T, "Fatal septic shock caused by transrectal needle biopsy of the prostate; a case report", Kansenshogaku Zasshi, 76, pp.893~897 (2002)
- Kato R, "Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy", Hinyokika Kiyo, 56, pp.453~456 (2010)
- Ozden E, "Incidence of acute prostatitis caused by extendedspectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy", Urology, 74, pp.119~123 (2009)
- Sabbagh R, "A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy", Can J Urol, 11, pp.2216~2219 (2004)
- Shigemura K, "Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy", World J Urol, 23, pp.356~360 (2005)
- Schaeffer AJ, "Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate", BJU Int, 100, pp.51~57 (2007)
- Batura D, "Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates", BJU Int, 107, pp.760~764 (2011)
- Katsumi Shigemura, "Efficacy of Combination Use of Beta-Lactamase Inhibitor with Penicillin and Fluoroquinolones for Antibiotic Prophylaxis in Transrectal Prostate Biopsy", Investigative and Clinical Urology, 52(4), pp.289~292 (2011), 대한비뇨기과학회
- Yasuda M, "Clinical effectiveness and safety of tazobactam", piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy, 2014, pp.20, 631~634
- Li CK, "Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy", Int J Infect Dis, 43, pp.7~12 (2016)
- Summers SJ, "An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy", World J Urol, 33, pp.2001~2007 (2015)
- Gottesman T, "The value of rectal cultures in treatment of sepsis following post-transrectal ultrasound-guided prostate biopsy", Urol Int, 95, pp.177~182 (2015)
- Phillips S, "The comparison of double gloving to single gloving in the theatre environment", J Perioper Pract, 21, pp.10~15 (2011)
- Misteli H, "Surgical glove perforation and the risk of surgical site infection", Arch Surg, 144, pp.553~558 (2009)
- Haynes AB, "A surgical safety checklist to reduce morbidity and mortality in a global population", N Engl J Med, 360, pp.491~499 (2009)
